DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Benefix (Coagulation Factor IX (Recombinant)) - Current Clinical Trials

 
 



Benefix Related Clinical Trials

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B [Completed]

Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects [Completed]

Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B [Completed]

Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients [Completed]

Post Marketing Observational Study of Reformulated BeneFIX [Completed]

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B [Completed]

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B [Completed]

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B [Completed]

BeneFIX Drug Use Results Survey [All-Case Surveillance] [Active, not recruiting]

Registry For Patients Treated With BeneFix In Usual Care Setting In Germany [Recruiting]

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX [Completed]

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B [Completed]

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B [Completed]

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients [Completed]

Post Marketing Study in Haemophilia B Patients Using Nonafact« (Human Coagulation Factor IX) [Completed]

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX« for Usual Use [Completed]

A Study to Compare the Pharmacokinetics and Safety of Replenine«-VF, Replenine« or Other Factor IX in Haemophilia B [Completed]

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B [Terminated]

GOLD-B: A Gene Therapy Study for Hemophilia B [Not yet recruiting]

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B [Completed]

Hemophilia B Gene Therapy - Spark [Active, not recruiting]

Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B [Recruiting]

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B [Active, not recruiting]

Phase I/IIa Study of FIXFc in Hemophilia B Patients [Completed]

An Open-study to Investigate the Safety and Efficacy of Replenine«-VF in Haemophilia B Subjects Undergoing Surgery [Completed]

A Study to Investigate the Safety and Efficacy of Replenine«-VF in Haemophilia B Patients Under the Age of 6 Years [Completed]

A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B [Completed]

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B [Recruiting]

BAX 326 Surgery Study in Hemophilia B Patients [Completed]

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B [Recruiting]

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B [Enrolling by invitation]

Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B [Recruiting]

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B [Recruiting]

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B [Not yet recruiting]

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B [Completed]

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B [Completed]

Natural History Study of Factor IX Treatment and Complications [Recruiting]

LTFU for Gene Transfer Subjects With Hemophilia B [Active, not recruiting]

A Study to Investigate the Safety and Efficacy of Replenine´┐Ż-VF in Haemophilia B Patients Undergoing Major Surgery. [Completed]

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B [Completed]

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency [Completed]

BAX 326 Pediatric Study [Completed]

An Open Study to Investigate the Safety and Efficacy of Replenine«-VF in Severe Haemophilia B Patients [Completed]

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B [Completed]

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes [Recruiting]

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B [Active, not recruiting]

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B [Completed]

BAX 326 (rFIX) Continuation Study [Recruiting]

IMMUNINE Pre-Treatment Study [Completed]

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS [Recruiting]

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor [Completed]

Study of Ataluren (PTC124«) in Hemophilia A and B [Suspended]

A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers [Completed]

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery [Completed]

Web-based Application for the Population Pharmacokinetic Service - Phase 1 [Recruiting]

Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease [Recruiting]

Viscosupplementation in Patients With Hemophilic Arthropathy [Completed]

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy [Completed]

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen [Completed]

Thrombin Generation Numerical Models Validation in Haemophilic Case [Completed]

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture [Recruiting]

An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia [Active, not recruiting]

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives [Completed]

Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven« in Healthy Male Subjects [Withdrawn]

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia [Completed]

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors [Completed]

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries [Completed]

Survey Evaluating the Psychosocial Effects of Living With Haemophilia [Completed]

Cooperative Study of Factor VIII Inhibitors [Completed]

A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B [Not yet recruiting]

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients [Recruiting]

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors [Completed]

Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador [Completed]

Socialization of Adult Men With Congenital Hemophilia A or B [Recruiting]

Osteoporosis and MRI Study in Hemophilia [Terminated]

Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World [Completed]

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia [Active, not recruiting]

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study [Completed]

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study [Completed]

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain [Completed]

Gait Evaluation in Haemophiliac Patients [Completed]

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain [Completed]

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs [Completed]

Project to Update the Study of Congenital Haemophilia in Spain [Completed]

Pharmacokinetics of Single Bolus Dose of NovoSeven« in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State [Completed]

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State [Completed]

Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects [Completed]

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients [Completed]

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects [Completed]

Observational Study Describing the Usual Clinical Practice Use of NovoSeven´┐Ż in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017